Purchase Order 15B41226P00000185

The Federal Medical Center Rochester, a unit of the Department of Justice Bureau of Prisons, awarded a purchase order to Pantherx Specialty, LLC for $58,926.80 on May 1, 2026. The order, designated Modification 1 (a funding action reducing the contract by $1,073.20), carries a ceiling value of $58,926.80 and firm fixed-price terms with an ultimate completion date of May 31, 2026. Performance occurs in Pittsburgh, Pennsylvania. The order is part of the B1 PANTHERX CRENESSITY pharmaceutical supply...

The U.S. Department of Justice Bureau of Prisons' Federal Medical Center Rochester awarded a $39,284.60 firm fixed-price purchase order to Pantherx Specialty, LLC on April 1, 2026, with an ultimate completion date of April 30, 2026. The contract, designated B1 - PANTHERX - CRENESSITY, does not utilize a small business set-aside. Pantherx Specialty, LLC, which operates as Pantherx Specialty Pharmacy and is headquartered in Pittsburgh, Pennsylvania, will perform work at its Pittsburgh, PA...

<p>Federal Medical Center Rochester issued a purchase order to Foundation Care LLC on July 15, 2026, for $14,385.75 to supply Foundation Care medication (crenessity), with an ultimate completion date of August 31, 2026.</p> <p>Performance occurs in Sand Lake, Florida. The order is firm fixed price with no set-aside designation. This is a commercial pharmaceutical supply purchase order for oncology and hematology medications supplied to a federal correctional healthcare facility.</p>

The Department of Justice Bureau of Prisons Federal Medical Center Rochester awarded a $43,869.35 firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy and a subsidiary of Centene Corporation, for pharmacy services. The order is for Pantherx to provide pharmaceutical products and services to inmates at the Federal Medical Center Rochester facility in Pittsburgh, Pennsylvania from July 31, 2023 through August 4, 2023. As the Bureau of Prisons...

The Federal Medical Center Rochester, operated by the Department of Justice Bureau of Prisons, awarded a modification to Pantherx Specialty, LLC, a specialty pharmacy headquartered in Pittsburgh, Pennsylvania, resulting in a decrease of $1,144.22 to the contract ceiling value, which now stands at $38,140.38. This firm fixed-price purchase order, issued on January 1, 2026, with an ultimate completion date of January 31, 2026, does not utilize a small business set-aside designation. Pantherx...

<p>The Federal Medical Center Rochester issued a $5,000 delivery order to McKesson Corporation on July 15, 2026, for controlled medications with an ultimate completion date of August 31, 2026.</p> <p>Place of performance is Irving, TX. The order is priced on a firm fixed-price basis with no set-aside designation.</p>

<p>The Federal Medical Center Rochester issued a purchase order to McKesson Corporation on February 1, 2026, with a ceiling value of $1,350.07 for controlled medications. The order is firm fixed price with an ultimate completion date of February 28, 2026. Performance occurs in Irving, Texas. No set-aside was used. This represents a modification (MOD 2) that decreased the order value by $2,299.86 from an earlier funded amount.</p>

<p>Federal Medical Center Rochester issued a purchase order to McKesson Corporation on April 1, 2026, valued at $7,543.70, for pharmaceutical and medical supplies on an open-market basis. The order carries no set-aside designation and is firm fixed price. Place of performance is Irving, Texas. Ultimate completion is April 30, 2026. This modification represents a decrease of $5,456.30 from a prior order value.</p>

<p>Federal Medical Center Rochester awarded a purchase order to McKesson Corporation on February 1, 2026, with a ceiling value of $7,614.61 for pharmaceutical and medical supplies. The modification reflects a decrease of $5,385.39 from a prior obligation. Place of performance is Irving, Texas. The order carries firm fixed pricing with an ultimate completion date of February 28, 2026. No small business set-aside applies.</p>

<p>The Federal Medical Center Rochester awarded a purchase order to Eversana Life Science Services LLC for $27,090.58 on July 15, 2026, with completion by August 31, 2026. The order procures Elfabrio (vestronidase alfa-vjbk), a specialty pharmaceutical product, for delivery to Wildwood, Missouri. This is a firm fixed-price purchase order with no set-aside designation.</p>